CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 159 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $94,009,000 | +51.7% | 2,781,344 | +5.0% | 0.00% | +50.0% |
| Q1 2021 | $61,977,000 | -17.1% | 2,649,702 | +2.0% | 0.00% | 0.0% |
| Q4 2020 | $74,782,000 | +78.2% | 2,596,599 | +25.3% | 0.00% | 0.0% |
| Q3 2020 | $41,972,000 | -24.1% | 2,071,665 | +12.5% | 0.00% | 0.0% |
| Q2 2020 | $55,318,000 | +34.0% | 1,840,931 | +40.1% | 0.00% | 0.0% |
| Q1 2020 | $41,289,000 | -19.4% | 1,313,701 | +20.8% | 0.00% | 0.0% |
| Q4 2019 | $51,236,000 | +835.8% | 1,087,584 | +28.3% | 0.00% | – |
| Q3 2019 | $5,475,000 | -45.7% | 847,455 | +3.3% | 0.00% | – |
| Q2 2019 | $10,074,000 | +2.4% | 820,432 | +13.0% | 0.00% | – |
| Q1 2019 | $9,842,000 | +2204.9% | 726,325 | +582.3% | 0.00% | – |
| Q4 2018 | $427,000 | -66.5% | 106,457 | -43.9% | 0.00% | – |
| Q3 2018 | $1,276,000 | – | 189,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |